118 related articles for article (PubMed ID: 4018139)
21. [3H]dopamine labeling of D3 dopaminergic sites in human, rat, and calf brain.
List SJ; Seeman P
J Neurochem; 1982 Nov; 39(5):1363-73. PubMed ID: 7119802
[TBL] [Abstract][Full Text] [Related]
22. Reduced dopaminergic binding during aging in the rodent striatum.
Severson JA; Finch CE
Brain Res; 1980 Jun; 192(1):147-62. PubMed ID: 6155174
[TBL] [Abstract][Full Text] [Related]
23. In vivo displacement by 3-PPP enantiomers of N,N-dipropyl-5,6-ADTN from dopamine receptor-binding sites in rat striatum.
Carlsson A; Löfberg L
J Neural Transm; 1985; 64(3-4):173-85. PubMed ID: 4086990
[TBL] [Abstract][Full Text] [Related]
24. Dopamine receptor binding in inbred mice: strain differences in mesolimbic and nigrostriatal dopamine binding sites.
Boehme RE; Ciaranello RD
Proc Natl Acad Sci U S A; 1981 May; 78(5):3255-9. PubMed ID: 6166945
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological profile of a chromanamine analogue (DP-6OH-3CA) of the selective presynaptic dopamine agonist N,N-dipropyl-7-hydroxy-2-aminotetralin.
Vermue NA; Dijkstra D; Horn AS
J Pharm Pharmacol; 1988 Aug; 40(8):574-7. PubMed ID: 2907015
[TBL] [Abstract][Full Text] [Related]
26. ACTH/MSH-like peptides inhibit the binding of dopaminergic ligands to the dopamine D2 receptor in vitro.
Florijn WJ; De Boer T; Tonnaer JA; Van Nispen JW; Versteeg DH
Eur J Pharmacol; 1991 May; 207(1):43-50. PubMed ID: 1680721
[TBL] [Abstract][Full Text] [Related]
27. Chronic D-amphetamine and phencyclidine: effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems.
Robertson HA
Brain Res; 1983 May; 267(1):179-82. PubMed ID: 6860944
[TBL] [Abstract][Full Text] [Related]
28. In vivo dopamine receptor binding studies with a non-radioactively labeled agonist, dipropyl-5,6-ADTN.
Feenstra MG; Rollema H; Mulder TB; Westerink BH; Horn AS
Life Sci; 1983 Mar; 32(12):1313-23. PubMed ID: 6403788
[TBL] [Abstract][Full Text] [Related]
29. Binding characteristics of the dopamine uptake inhibitor [3H]nomifensine to striatal membranes.
Dubocovich ML; Zahniser NR
Biochem Pharmacol; 1985 Apr; 34(8):1137-44. PubMed ID: 3158318
[TBL] [Abstract][Full Text] [Related]
30. Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics.
Richfield EK
Brain Res; 1991 Feb; 540(1-2):1-13. PubMed ID: 1829013
[TBL] [Abstract][Full Text] [Related]
31. Evidence for loss of brain [3H]spiroperidil and [3H]ADTN binding sites in rabbit brain with aging.
Thal LJ; Horowitz SG; Dvorkin B; Makman MH
Brain Res; 1980 Jun; 192(1):185-94. PubMed ID: 7378779
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological profiles of three new, potent and selective dopamine receptor agonists: N-0434, N-0437 and N-0734.
Van der Weide J; De Vries JB; Tepper PG; Horn AS
Eur J Pharmacol; 1986 Jun; 125(2):273-82. PubMed ID: 3743637
[TBL] [Abstract][Full Text] [Related]
33. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
Neve KA; Altar CA; Wong CA; Marshall JF
Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological profile of N,N dipropyl-8-hydroxy-3-chromanamine, an oxygen isostere of the dopamine agonist N,N dipropyl-5-hydroxy-2-aminotetralin with enhanced presynaptic selectivity.
Vermue NA; Kaptein B; Tepper PG; de Vries JB; Horn AS
Arch Int Pharmacodyn Ther; 1988; 293():37-56. PubMed ID: 3421784
[TBL] [Abstract][Full Text] [Related]
35. Interaction of the putative dopamine autoreceptor agonists 3-PPP and TL-99 with [3H]apomorphine binding sites in rat striatal membranes.
Williams M; Totaro JA
Eur J Pharmacol; 1982 Dec; 86(1):35-42. PubMed ID: 7160432
[TBL] [Abstract][Full Text] [Related]
36. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
Makman MH; Dvorkin B
Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
[TBL] [Abstract][Full Text] [Related]
37. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
Jarvis MF; Schulz R; Hutchison AJ; Do UH; Sills MA; Williams M
J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819
[TBL] [Abstract][Full Text] [Related]
38. [Effect of in vitro serotonin on dopaminergic binding sites in rat striatal membranes].
Oelssner W; Raubach KH; Oelssner W
Biomed Biochim Acta; 1983; 42(7-8):931-6. PubMed ID: 6651809
[TBL] [Abstract][Full Text] [Related]
39. In vitro binding of a novel dopamine D3 receptor ligand: [125I]trans-7-OH-PIPAT-A.
Kung MP; Kung HF; Chumpradit S; Foulon C
Eur J Pharmacol; 1993 Apr; 235(1):165-6. PubMed ID: 8519278
[TBL] [Abstract][Full Text] [Related]
40. Selective reduction of one class of dopamine receptor binding sites in the corpus striatum of aged rats.
De Blasi A; Mennini T
Brain Res; 1982 Jun; 242(2):361-4. PubMed ID: 7116143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
